Folgen
Najmeh Yardehnavi
Najmeh Yardehnavi
School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Bestätigte E-Mail-Adresse bei goums.ac.ir
Titel
Zitiert von
Zitiert von
Jahr
An overview on application of phage display technique in immunological studies
A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, ...
Asian Pacific Journal of Tropical Biomedicine 7 (7), 599-602, 2017
672017
Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods
M Mehrpouya, Z Pourhashem, N Yardehnavi, M Oladnabi
Journal of cellular physiology 234 (12), 21425-21435, 2019
372019
A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation
N Yardehnavi, M Behdani, KP Bagheri, A Mahmoodzadeh, H Khanahmad, ...
The FASEB Journal 28 (9), 4004, 2014
362014
Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library
R Jahdasani, FR Jamnani, M Behdani, M Habibi-Anbouhi, N Yardehnavi, ...
Toxicon 124, 83-93, 2016
142016
Non-coding CK19 RNA in peripheral blood and tissue of breast cancer patients
M Oloomi, N Yardehnavi, S Bouzari, N Moazzezy
Acta Medica Iranica, 75-86, 2013
112013
An in-silico approach to find a peptidomimetic targeting extracellular domain of HER3 from a HER3 Nanobody
Z Pourhashem, M Mehrpouya, N Yardehnavi, A Eslamparast, ...
Computational biology and chemistry 68, 39-42, 2017
42017
Iranian biopharmaceutical companies: products and services
A Eslamparast, N Yardehnavi, F Tavakoli, F Kazemi-Lomedasht
Health Biotechnology and Biopharma 1 (1), 35-45, 2017
32017
Anticancer activity of H. lepturus venom and its hemolytic fraction (heminecrolysin)
D Shahbazzadeh, N Yardehnavi, F Kazemi-Lomedasht, KP Bagheri, ...
HBB. Heal. Biotechnol. Biopharma 1, 46-53, 2017
32017
Cytotoxicity, anti-adhesive and anti-angiogenic effects of Caspian Cobra snake (Naja oxiana) venom on human endothelial cells
A Oghalaie, M Behdani, N Yardehnavi, D Shahbazzadeh, ...
Health Biotech Pharm 1, 53-62, 2017
32017
Venomics and antivenomics data: current and future perspective
M Oladnabi, S Omidi, M Mehrpouya, A Azadmehr, F Kazemi-Lomedasht, ...
Archives of Biotechnology and Biomedicine 5 (1), 026-031, 2021
22021
An in silico study to find angiogenesis inhibitory role for Naja oxiana snake venom cytotoxins
Z Pourhashem, N Yardehnavi, M Behdani, F Kazemi-Lomedasht
22018
Venomics and antivenomics data: Current and future perspective
S Omidi, M Mehrpouya, M Oladnabi, A Azadmehr, F Kazemi-Lomedasht, ...
2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–12